John Menditto | VP, IR and Corporate Communications |
Dr. David Mazzo | President and Chief Executive Officer |
Dr. Kristen Buck | EVP, Research and Development and Chief Medical Officer |
James Nisco | VP, Finance and Treasury |
Steve Brozak | WBB Securities |
Pete Enderlin | MAZ Partners |
Kemp Dolliver | Brookline Capital Markets |
Welcome to the Lisata Therapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Following managements' prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, the call is being recorded today, Tuesday, August 15, 2023.
I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Lisata.